Summary
Thermo Electron Corporation (TMO) reported its third-quarter 2001 financial results, highlighting a 10% increase in diluted cash operating Earnings Per Share (EPS) to $0.22, up from $0.20 in the prior year period. This growth was achieved despite a 1% decline in organic revenue and challenging economic conditions, including impacts from the September 11th events which are estimated to have reduced revenue by approximately 1%. The company is actively implementing restructuring measures to improve margins and efficiency, including workforce reductions and facility consolidations. The company's performance was mixed across its segments. The Life Sciences sector showed resilience with 6% organic revenue growth and strong demand for its products. However, the Optical Technologies and Measurement and Control sectors experienced revenue declines, primarily due to softness in their respective end markets, particularly in semiconductor, telecommunications, and cyclical industries. Management expressed confidence in the company's technological strengths and ongoing efficiency drives to navigate the economic headwinds and expects margin improvement in the fourth quarter.
Key Highlights
- 1Diluted cash operating EPS increased 10% to $0.22 for Q3 2001, compared to $0.20 in Q3 2000.
- 2Organic revenue declined 1% for Q3 2001, impacted by a 1% foreign currency headwind.
- 3Total revenues for Q3 2001 were $513 million, down from $547 million in Q3 2000, with ~$32 million of the difference attributed to divestitures and currency effects.
- 4Life Sciences sector achieved 6% organic revenue growth, driven by clinical diagnostics and laboratory information systems.
- 5Optical Technologies sector saw an 8% organic revenue decline, significantly impacted by weakness in semiconductor and telecommunications markets.
- 6The company is undergoing significant restructuring, having reduced headcount by over 600 and plans to eliminate an additional 300-500 positions in Q4 2001.
- 7Management expects cash operating margin to rebound to above 11% in Q4 2001 and forecasts Q4 diluted cash operating EPS between $0.23 and $0.26.